Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to moderate weight loss as a secondary effect due to its action as a GLP-1 ...

Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in ...

Diabetes care can greatly benefit from the implementation of telemedicine, but older adults still face accessibility barriers ...

With more than 25 years of clinical leadership, we’ve developed a connected ecosystem that brings together diabetes ...

A groundbreaking study published in the journal Current Pharmaceutical Analysis has uncovered the potential of essential oil ...

At the India Today Conclave Mumbai 2025, Dr Avi Roy called GLP-1s a tool for living longer, not just losing weight. To probe the science and skepticism, we spoke with an endocrinologist who weighed in ...

In a Naples clinic, an unexpected link between a diabetes medication and relief from migraines has caused a stir in the ...

The print component of “Future of Diabetes” is distributed in today’s edition of USA Today. Copies will be distributed on ...

Research on alcohol and type 2 diabetes shows mixed results. Some studies suggest that drinking alcohol in moderation might ...

As medical technology rapidly evolves—particularly in areas like in vitro diagnostics and connected health devices—the regulatory environment continually adapts to emerging innovations and tightening ...

The El Paso Center for Diabetes celebrated the grand opening of its new facility located at 8700 Montana Avenue.

The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...